4 mg REXTOVY Nasal Spray 0.4 mg Naloxone HCl Intramuscular Injection 2 mg Naloxone HCl Intravenous Infusion Population N=25 N=27 N=26 AUC0-6h (ng*hr/mL ) 6.41 ± 1.33 1.54 ± 1.27 8.44 ± 1.34 AUC0-inf (ng*hr/mL ) 6.63 ± 1.32 1.60 ± 1.27 8.64 ± 1.33 Cmax (ng/mL) ...
0.4 mg/mL Protect from light.For Intravenous, Intramuscular, or Subcutaneous Use Hospira PRINCIPAL DISPLAY PANEL - 10 mL Vial Label 10 mL Multiple-dose NALOXONE HCl Injection, USP4 mg/10 mL (0.4 mg/mL) Protect from light. For I.V., I.M. or S.C. use. Dist. by Hospira, Inc.,Lake...
CAS编号:357-08-4 分子式:C19H21NO4·HCl 分子量:363.84 PubChem编号:5464092 货号(SKU)包装规格是否现货价格数量 N129470-250mg 250mg期货 现价:¥372.90 +- 大包装询价添加到收藏夹比较SDS中文版DATASHEET 查看相关系列 Opioid Receptor (112) Skip to the end of the images gallery ...
溶解性Soluble in water (73 mg/ml), ethanol (3.3 mg/ml), methanol (50 mg/ml), and DMSO (73 mg/ml). Insoluble in ether. 敏感性对光和湿度敏感 存贮条件储存温度 2-8°C 熔点200-205 °C 产品介绍Naloxone HCl是阿片反向激动剂药物,用来中和过量阿片的效果。
Naloxone hydrochloride (Naloxone HCl),又称盐酸纳洛酮,是阿片受体的拮抗剂,具有神经保护作用。阿片受体的激活调节许多生物功能,包括疼痛感知、动机、运动、激素分泌和奖赏。Naloxone可用于解除麻醉性镇痛药所致呼吸抑制和成瘾性以及吗啡类药物的急性中毒。 产品性质 ...
1) 货号: 03121128; 2) 中文品名: 盐酸纳洛酮 二水标准品; 3) 英文品名: Naloxone hydrochloride dihydrate; 4) CAS No. 51481-60-8; 5) 分子式、分子量; C19H21NO4. HCl . 2H2O;; 6)同位素含量: ; 7) 规格: 1 mg, 5
Naloxone hydrochloride (molecular formula C19H21NO4HCl, CAS number 357-08-4) was synthetized in 1960 by Fishman in the laboratory of Lewenstein. The inventors were granted a USA patent in 1966 [20] claiming that naloxone was a “more potent antagonist to the respiratory effects of potent analg...
国籍: 美国 产品介绍: 英文名称:Naloxone hydrochloride;Naloxone HClCAS:357-08-4纯度:99.80% 包装信息:100 mg;200 mg;25 mg;50 mg 备注:REAGENT;FOR LABORATORY USE ONLY CB指数: 58 网址: https://www.targetmol.com/ 相关信息: 全球销售网络 产品目录(32239) 用户评价 1...
NARCAN Nasal Spray4 mg is supplied as Carton containing two (2) blister packages (NDC69547- 353-02) each with a single spray device. NARCAN HCl Nasal Spray is not made with natural rubber latex. Storage And Handling Store NARCAN Nasal Spray in the blister and cartons provided. ...
The further decrease in opiate sensitivity was substantially reduced by naloxone-HCl (IP) in a dose of 10 mg/kg given 30 min before and 8 h after the 200 mg/kg MS injections, or a dose of 4 mg/kg given 45 min after the MS. It was concluded that LDR curve flattening produced by ...